GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » Revenue

GoodRx Holdings (GoodRx Holdings) Revenue : $750.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings Revenue?

GoodRx Holdings's revenue for the three months ended in Dec. 2023 was $196.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $750.3 Mil. GoodRx Holdings's Revenue per Share for the three months ended in Dec. 2023 was $0.49. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.83.

Warning Sign:

GoodRx Holdings Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of GoodRx Holdings was -1.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, GoodRx Holdings's highest 3-Year average Revenue per Share Growth Rate was 38.30% per year. The lowest was -3.00% per year. And the median was 20.10% per year.


GoodRx Holdings Revenue Historical Data

The historical data trend for GoodRx Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GoodRx Holdings Revenue Chart

GoodRx Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 388.22 550.70 745.42 766.55 750.27

GoodRx Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.11 183.99 189.68 179.96 196.64

Competitive Comparison of GoodRx Holdings's Revenue

For the Health Information Services subindustry, GoodRx Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GoodRx Holdings's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's Revenue falls into.



GoodRx Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $750.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GoodRx Holdings  (NAS:GDRX) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


GoodRx Holdings Revenue Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


GoodRx Holdings (GoodRx Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2701 Olympic Boulevard, Santa Monica, CA, USA, 90404
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Executives
Scott Wagner officer: Interim Chief Executive Office C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri officer: Chief Operating Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey officer: Chief Accounting Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky officer: President & Consumer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc 10 percent owner 2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann officer: Chief Financial Officer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad officer: See Remarks 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji officer: President, Healthcare MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud director
Abdiel Capital Lp 10 percent owner C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016